Notice on Convening the 2024 Annual General Meeting
Filed with SSE · · 6 pages · Chinese
Suzhou Novoprotein Scientific Co., Ltd. on 6ix
Earlier from Suzhou Novoprotein Scientific
- Announcement on Changing the Implementation Sites of Some Investment Projects Financed by Raised Funds and Postponing Investment Projects Financed by Raised Funds
- Announcement on Changing Project Partners and Signing Accountants
- Announcement on Share Reduction Plan for Shareholders
- Announcement on the Results of Shareholding Reduction by Shareholders
- Announcement on Expected Loss in Annual Performance for 2024
Later from Suzhou Novoprotein Scientific
- Announcement on Results of Share Reduction by Shareholders
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Opening Special Settlement Account for Cash Management Products Using Raised Funds
- "Corporate Value and Return Enhancement" Action Plan 2025
- Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
Follow Suzhou Novoprotein Scientific into a list and get an email when it puts out news.
Follow Suzhou Novoprotein Scientific